Long-lived CD19-positive plasma cells
Long-lived CD19-positive plasma cells
批准号:
8868901
负责人:
David M Allman
金额:
$39.04万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-15 至 2016-06-30
关键词:
AblationAcuteAntibodiesAntibody ResponseAntigen ReceptorsAntigensAutoantibodiesAutoantigensAutoimmune DiseasesAutoimmunityB-Cell ActivationB-LymphocytesBiological ModelsBone MarrowCD19 geneCell DeathCell MaintenanceCell Surface ProteinsCell surfaceCellsChromatinChronicComplexCuesCytokine ReceptorsDataEventExhibitsFamilyGenerationsGenesGoalsHaptensHomeostasisHost DefenseImmunityImmunizationInterleukin-5KineticsKnowledgeLifeLongevityMaintenanceMediatingMemory B-LymphocyteModelingMusPTPRC genePhenotypePlasma CellsPlayPopulationProcessProteinsReceptors, Antigen, B-CellRecurrenceRelative (related person)RoleSerumSignal TransductionT-LymphocyteTestingTherapeuticTimeTransgenic Micebasecombatcytokinedifferential expressionextracellulargene repairmouse modelnull mutationplasma cell differentiationresearch studyresponsevaccination strategy
中文摘要
描述(由申请方提供):维持针对外源和自身抗原的血清抗体所需的信号和事件仍不明确。本申请的主要目的是评估骨髓(BM)中最近形成的分泌抗体的浆细胞在这些过程中的作用,并定义最近形成的和长寿命的浆细胞用于避免细胞死亡的细胞因子。为了实现这些目标,我们将:1)定义新形成的BM PC在长寿命抗体介导的免疫中的作用; 2)定义新形成的和长寿命的BM PC在抗体介导的自身免疫中的作用;和3)定义IL-5和BAFF家族细胞因子在维持TI抗原诱导的PC中的作用。这些研究将增强对非自身和自身抗原的长寿命抗体应答的形成和维持的潜在过程的认识,从而为优化疫苗接种策略和对抗抗体介导的自身免疫性疾病提供信息。
英文摘要
DESCRIPTION (provided by applicant): The signals and events required for maintaining serum antibodies to foreign and self- antigens remain poorly defined. The main goals of this application are to evaluate the role of recently formed antibody secreting plasma cells in the bone marrow (BM) in these processes, and to define the cytokines that recently formed and long-lived plasma cells employ to avoid cell death. To achieve these objectives we will: 1) Define the role of newly formed BM PCs in long-lived antibody-mediated immunity; 2) Define the role of newly formed and long-lived BM PCs in antibody-mediated autoimmunity; and 3) Define the roles of IL-5 and BAFF family cytokines in the maintenance of TI antigen-induced PCs. These studies will enhance knowledge of the processes underlying formation and maintenance of long-lived antibody responses to both non-self and self-antigens, and consequently inform strategies to optimize vaccination strategies and combat antibody mediated autoimmune disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biochemical Mechanisms for Sustained Humoral Immunity
-
批准号:10637251
-
项目类别:
-
资助金额:$64.81万
-
财政年份:2023
-
负责人:David M Allman
-
依托单位:
The Notch Pathway in Antigen Design
-
批准号:10575892
-
项目类别:
-
资助金额:$26.4万
-
财政年份:2023
-
负责人:David M Allman
-
依托单位:
Plasma Cell Regulation by Purinergic Receptors
-
批准号:10441466
-
项目类别:
-
资助金额:$20.31万
-
财政年份:2021
-
负责人:David M Allman
-
依托单位:
Plasma Cell Regulation by Purinergic Receptors
-
批准号:10240081
-
项目类别:
-
资助金额:$24.38万
-
财政年份:2021
-
负责人:David M Allman
-
依托单位:
Proteasome targeting for alloreactive plasma cells
-
批准号:10215534
-
项目类别:
-
资助金额:$69.17万
-
财政年份:2020
-
负责人:David M Allman
-
依托单位:
Proteasome targeting for alloreactive plasma cells
-
批准号:10443660
-
项目类别:
-
资助金额:$68.88万
-
财政年份:2020
-
负责人:David M Allman
-
依托单位:
Proteasome targeting for alloreactive plasma cells
-
批准号:10652461
-
项目类别:
-
资助金额:$65.66万
-
财政年份:2020
-
负责人:David M Allman
-
依托单位:
Plasma Cell Priming
-
批准号:9403332
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2017
-
负责人:David M Allman
-
依托单位:
Epigenetic Control of Plasma Cell Differentiation
-
批准号:9105812
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2015
-
负责人:David M Allman
-
依托单位:
Origins of serum IgA antibodies
-
批准号:9111850
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2014
-
负责人:David M Allman
-
依托单位:
Origins of serum IgA antibodies
-
批准号:9315100
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2014
-
负责人:David M Allman
-
依托单位:
Origins of serum IgA antibodies
-
批准号:8772548
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2014
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:8387887
-
项目类别:
-
资助金额:$38.93万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:8508182
-
项目类别:
-
资助金额:$36.64万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:8680129
-
项目类别:
-
资助金额:$39.01万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:9096003
-
项目类别:
-
资助金额:$39.07万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived antibody secreting cells
-
批准号:8066726
-
项目类别:
-
资助金额:$19.1万
-
财政年份:2010
-
负责人:David M Allman
-
依托单位:
Long-lived antibody secreting cells
-
批准号:7983146
-
项目类别:
-
资助金额:$23.14万
-
财政年份:2010
-
负责人:David M Allman
-
依托单位:
Aging of Early B Cell Precursors
-
批准号:7812028
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2006
-
负责人:David M Allman
-
依托单位:
Aging of Early B Cell Precursors
-
批准号:7268827
-
项目类别:
-
资助金额:$28.2万
-
财政年份:2006
-
负责人:David M Allman
-
依托单位:
海外基金